Enhancing nicotine vaccine immunogenicity with liposomes

Bioorganic and Medicinal Chemistry Letters

Volumn 23, Issue 4, 2013, Pages 975-978

  Lockner, Jonathan W ^a   Ho, Sam On ^b   McCague, Karen C ^a   Chiang, Su Ming ^b   Do, Thai Q ^b   Fujii, Gary ^b   Janda, Kim D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Molecular Express Inc   (United States)

Author keywords

Adjuvant; Immunopharmacotherapy; Liposome; Nicotine; Vaccine

Indexed keywords

[2,3 BIS(PALMITOYLOXY)PROPYL] N PALMITOYLCYSTEINYLALANYLGLYCINE; ANTIBODY CONJUGATE; HAPTEN; IMMUNOLOGICAL ADJUVANT; LIPOSOME; NICOTINE VACCINE; PHOSPHORYL LIPID A; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; VESIVAX;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOGENICITY; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; RADIOIMMUNOASSAY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; HUMANS; LIPOSOMES; MICE; NICOTINE; VACCINES;

MURINAE;

EID: 84872920566     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.12.048     Document Type: Article

References (42)

1. A.Y. Moreno, and K.D. Janda Pharmacol., Biochem. Behav. 92 2009 199
2. M.M. Meijler, M. Matsushita, P. Wirsching, and K.D. Janda Curr. Drug Discovery Technol. 1 2004 77
3. J.B. Treweek, and K.D. Janda Mol. Pharm. 9 2012 969
4. G.N. Stowe, L.F. Vendruscolo, S. Edwards, J.E. Schlosburg, K.K. Misra, G. Schulteis, A.V. Mayorov, J.S. Zakhari, G.F. Koob, and K.D. Janda J. Med. Chem. 54 2011 5195
5. A.Y. Moreno, A.V. Mayorov, and K.D. Janda J. Am. Chem. Soc. 133 2011 6587
6. A.Y. Moreno, M.R. Azar, N.A. Warren, T.J. Dickerson, G.F. Koob, and K.D. Janda Mol. Pharm. 7 2010 431
7. D.A. Gorelick Future Med. Chem. 4 2012 227
8. J. Hartmann-Boyce, K. Cahill, D. Hatsukami, and J. Cornuz Cochrane Database Syst. Rev. 8 2012 CD007072
9. S. Isomura, P. Wirsching, and K.D. Janda J. Org. Chem. 66 2001 4115
10. M.M. Meijler, M. Matsushita, L.J. Altobell 3rd, P. Wirsching, and K.D. Janda J. Am. Chem. Soc. 125 2003 7164
11. B.P. De, J.L. Boyer, O. Alsaied, A.Y. Moreno, K. Janda, S. Worgall, and R.G. Crystal Mol. Ther. 17 2009 S281
12. J.B. Rosenberg, B.P. De, M.J. Hicks, A.Y. Moreno, K.D. Janda, S.M. Kaminsky, and R.G. Crystal Mol. Ther. 20 2012 S127
13. M.J. Hicks, J.B. Rosenberg, B.P. De, O. Pagovich, C.N. Young, J.P. Qiu, S.M. Kaminsky, N.R. Hackett, S. Worgall, K.D. Janda, R.L. Davisson, and R.G. Crystal Mol. Ther. 20 2012 S43
14. M.J. Hicks, J.B. Rosenberg, B.P. De, O.E. Pagovich, C.N. Young, J.-P. Qiu, S.M. Kaminsky, N.R. Hackett, S. Worgall, K.D. Janda, R.L. Davisson, and R.G. Crystal Sci. Transl. Med. 2012 4
15. V.E. Schijns, and E.C. Lavelle Expert Rev. Vaccines 10 2011 539
16. A.G. Allison, and G. Gregoriadis Nature 252 1974 252
17. K. Uemura, R.A. Nicolotti, H.R. Six, and S.C. Kinsky Biochemistry (Mosc) 13 1974 1572
18. N.M. Garçon, and H.R. Six J. Immunol. 146 1991 3697
19. D.S. Watson, A.N. Endsley, and L. Huang Vaccine 30 2012 2256
20. R.I. Jølck, L.N. Feldborg, S. Andersen, S.M. Moghimi, and T.L. Andresen Adv. Biochem. Eng. Biotechnol. 125 2011 251
21. E.H. Cerny, R. Lévy, J. Mauel, M. Mpandi, M. Mutter, C. Henzelin-Nkubana, L. Patiny, G. Tuchscherer, and T. Cerny Onkologie 25 2002 406
22. P. Maurer, G.T. Jennings, J. Willers, F. Rohner, Y. Lindman, K. Roubicek, W.A. Renner, P. Muller, and M.F. Bachmann Eur. J. Immunol. 35 2005 2031
23. Janda, K. D. Nicotine haptens, immunoconjugates and their uses. U.S. 2012/0225087 A1, Sep. 6, 2012.
24. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Anal. Biochem. 150 1985 76
25. Fujii, G.; Szoka, F. C., Jr.; Watson, D. S. Methods and compositions for liposomal formulations of antigens and uses thereof. U.S. 2010/0226973 A1, Sep. 9, 2010.
26. W.A. Ernst, H.J. Kim, T.M. Tumpey, A.D. Jansen, W. Tai, D.V. Cramer, J.P. Adler-Moore, and G. Fujii Vaccine 24 2006 5158
27. K. Olson, P. Macias, S. Hutton, W.A. Ernst, G. Fujii, and J.P. Adler-Moore Vaccine 28 2009 548
28. J. Adler-Moore, M. Munoz, H. Kim, J. Romero, T. Tumpey, H. Zeng, C. Petro, W. Ernst, S. Kosina, G. Jimenez, and G. Fujii Vaccine 29 2011 4460
29. I. Fernandes, B. Frisch, S. Muller, and F. Schuber Mol. Immunol. 34 1997 569
30. S. Espuelas, A. Roth, C. Thumann, B. Frisch, and F. Schuber Mol. Immunol. 42 2005 721
31. C.R. Alving, M. Rao, N.J. Steers, G.R. Matyas, and A.V. Mayorov Expert Rev. Vaccines 11 2012 733
32. C.R. Alving, and M. Rao Vaccine 26 2008 3036
33. G.T. Hermanson Bioconjugate Techniques 2nd ed. 2008 Academic Press San Diego p 748
34. E. Jaenicke, K. Büchler, H. Decker, J. Markl, and G.F. Schröder IUBMB Life 63 2011 183
35. R.L. Richards, M. Rao, N.M. Wassef, G.M. Glenn, S.W. Rothwell, and C.R. Alving Infect. Immun. 66 1998 2859
36. R.L. Richards, C.R. Alving, and N.M. Wassef J. Pharm. Sci. 85 1996 1286
37. C.R. Alving Immunobiology 187 1993 430
38. J.N. Verma, M. Rao, S. Amselem, U. Krzych, C.R. Alving, S.J. Green, and N.M. Wassef Infect. Immun. 60 1992 2438
39. C.R. Alving, J.N. Verma, M. Rao, U. Krzych, S. Amselem, S.M. Green, and N.M. Wassef Res. Immunol. 143 1992 197
40. C.R. Alving J. Immunol. Methods 140 1991 1
41. R. Müller Methods Enzymol. 92 1983 589
42. D.E. Keyler, S.A. Roiko, C.A. Earley, M.P. Murtaugh, and P.R. Pentel Int. Immunopharmacol. 8 2008 1589